|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment |
Fibrilación Auricular e Insuficiencia Cardíaca Congestiva: Factores de Riesgo, Mecanismos y Tratamiento |
||
|
Fibrilación auricular, insuficiencia cardíaca congestiva, tratamiento farmacológico, ablación |
Atrial Fibrillation, congestive heart failure, pharmacological treatment, ablation |
||
|
Heist EK, Ruskin JN |
JN Ruskin, Cardiac Arrhytmia Service, Massachusetts General Hospital, Harvard Medical School MA 02114 Boston EE.UU. |
||
|
Pfizer Inc. MercK & Co. Harvard MIT Healoth Sciences. Tecnology-Beth Israel Deaconess Medical Center |
Los autores no manifiestan conflictos de interés |
||
|
Cardiac Arrhytmia Service, Massachusetts General Hospital, Harvard Medical School |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|